RU2003117263A - METHOD FOR PREDICTING THERAPY EFFECTIVENESS IN LEPRA PATIENTS - Google Patents

METHOD FOR PREDICTING THERAPY EFFECTIVENESS IN LEPRA PATIENTS

Info

Publication number
RU2003117263A
RU2003117263A RU2003117263/15A RU2003117263A RU2003117263A RU 2003117263 A RU2003117263 A RU 2003117263A RU 2003117263/15 A RU2003117263/15 A RU 2003117263/15A RU 2003117263 A RU2003117263 A RU 2003117263A RU 2003117263 A RU2003117263 A RU 2003117263A
Authority
RU
Russia
Prior art keywords
patients
lepra
therapy effectiveness
effectiveness
predicting therapy
Prior art date
Application number
RU2003117263/15A
Other languages
Russian (ru)
Other versions
RU2247374C1 (en
Inventor
Анатолий Афанасьевич Ющенко
Вячеслав Петрович Цемба
Валентин Захарович Наумов
Original Assignee
Научно-исследовательский институт по изучению лепры Министерства здравоохранения Российской Федерации
Filing date
Publication date
Application filed by Научно-исследовательский институт по изучению лепры Министерства здравоохранения Российской Федерации filed Critical Научно-исследовательский институт по изучению лепры Министерства здравоохранения Российской Федерации
Priority to RU2003117263/15A priority Critical patent/RU2247374C1/en
Priority claimed from RU2003117263/15A external-priority patent/RU2247374C1/en
Publication of RU2003117263A publication Critical patent/RU2003117263A/en
Application granted granted Critical
Publication of RU2247374C1 publication Critical patent/RU2247374C1/en

Links

Claims (1)

Способ прогнозирования эффективности терапии у больных лепрой, состоящий в исследовании метаболизма клеток гемопоэтического происхождения, отличающийся тем, что определяют коэффициент эффективности терапии и по его значению, равному 1,20 условных единиц и выше, прогнозируют эффективность терапии у больных лепрой.A method for predicting the effectiveness of therapy in patients with leprosy, consisting in a study of the metabolism of cells of hematopoietic origin, characterized in that they determine the coefficient of effectiveness of therapy and, by its value equal to 1.20 conventional units or higher, predict the effectiveness of therapy in patients with leprosy.
RU2003117263/15A 2003-06-09 2003-06-09 Method for predicting leprosy patient treatment effectiveness RU2247374C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003117263/15A RU2247374C1 (en) 2003-06-09 2003-06-09 Method for predicting leprosy patient treatment effectiveness

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003117263/15A RU2247374C1 (en) 2003-06-09 2003-06-09 Method for predicting leprosy patient treatment effectiveness

Publications (2)

Publication Number Publication Date
RU2003117263A true RU2003117263A (en) 2004-12-27
RU2247374C1 RU2247374C1 (en) 2005-02-27

Family

ID=35286381

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003117263/15A RU2247374C1 (en) 2003-06-09 2003-06-09 Method for predicting leprosy patient treatment effectiveness

Country Status (1)

Country Link
RU (1) RU2247374C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2688156C2 (en) * 2017-08-21 2019-05-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт по изучению лепры" Министерства здравоохранения Российской Федерации Method for assessing efficiency of the treatment of leprosy with polymerase chain reaction

Similar Documents

Publication Publication Date Title
DK1948235T3 (en) Methods to determine the effectiveness of adalimumab in patients with Bechterew's disease with CTX-II and MMP3 as biomarkers
LTC1673106I2 (en) HPV 45 L1 optimized expression in yeast
LTPA2015050I1 (en) OPTIMIZED HPV 52 L1 EXPRESSION IN YEAST
IS8090A (en) Composition to improve wit and memory
DE602004003162D1 (en) Improvements in or relating to dynamic imaging
HK1131882A1 (en) Educated nkt cells and their uses in the treatment of immune-related disorders
NO20043864L (en) Copper-based alloy and its use in carburizing environment
IL217561A0 (en) Use of cytokininis to increase the ratio of wild type to mutant protein in cells
RU2003117263A (en) METHOD FOR PREDICTING THERAPY EFFECTIVENESS IN LEPRA PATIENTS
ITRM20040058A1 (en) HMGB1 INHIBITORS AND ANTAGONISTS ABLE TO REGULATE THE PROLIFERATION OF SMOOTH AND ENDOTELIAL MUSCLE CELLS.
WO2005094338A3 (en) Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
NO20055228D0 (en) Stem Cells with Oct Sensitivity to SDF-1 and Methods for Preparation and Use thereof
GB0213979D0 (en) Improvements in and relating to analysis
DE602004017166D1 (en) GABAPENTINTANNAT IN LIQUID AND / OR HALF-FIXED DOSAGE FORMS
AU2003209737A8 (en) Methods for increasing the oil content in plants by reducing the content of one or more storage proteins
GB0210486D0 (en) Improvements in or relating to transducer testing
ITPN990098A0 (en) ABSORPTION REFRIGERATOR BUILT TO PREVENT ITS INTERNAL CORROSION.
SE0202245D0 (en) Novel sequence information and methods for its use in diagnosis and therapy VI.2
ITMI20051170A1 (en) "COMPRESSION AND PROCEDURE TO MAKE IT WORK"
SE0201956D0 (en) Novel sequence information and methods for its use in diagnosis and therapy VI
SE0202252D0 (en) Novel sequence information and methods for its use in diagnosis and therapy XII
SE0202251D0 (en) Novel sequence information and methods for its use in diagnosis and therapy XI
FI7612U1 (en) Arrangements in connection with bridge pillars
SE0201867D0 (en) Novel sequence information and methods for its use in diagnosis and therapy I
ITBO20020108A1 (en) COMPUTERIZED PSYCHO-ATTUDINAL TEST THAT, THROUGH THE ANALYSIS OF MENTAL ATTITUDES, ALLOWS TO ASSESS THE POTENTIALS AND THE COMPETENCES